Logo Prima Biomed

Welcome to the Newsroom

18 May 2017

Data from Prima BioMed AIPAC Clinical Trial to be Presented at 2017 ASCO Conference



SYDNEY, AUSTRALIA - Prima BioMed Ltd (ASX: PRR; NASDAQ: PBMD) (“Prima” or the

“Company”) today announced that an abstract and poster have been accepted for presentation

at the American Society of Clinical Oncology (ASCO) 53rd annual meeting to be held in Chicago,

Illinois, 2-6 June 2017.